Bond.az White LogoBond.az Black Logo

Raymond James Upgrades SM Energy on Oil Strength

Raymond James upgrades SM Energy to Outperform with $55 target on oil strength. SM Energy benefits from Iran war oil price surge.

Henry Walker
ByHenry Walker- Senior Editor
|
0

Raymond James upgraded SM Energy (NYSE:SM) to Outperform from Underperform and set a price target of $55.00.

The firm said SM Energy has been one of the biggest beneficiaries in its coverage universe of the oil price increase following the Iran war. The analyst noted that despite the stock's recent run, a bullish oil outlook relative to the current strip provides upside potential. The stock currently trades at $34.32, near its 52-week high of $34.44, with shares up 90% over the past six months and 85% year-to-date.

SM Energy has reduced absolute debt by approximately $700 million following its merger close. The company expects leverage to fall below 1x by the fourth quarter of 2026, with the possibility of reaching that level earlier under the firm's oil outlook.

The company plans to begin share buybacks in the second quarter of 2026 and continue building free cash flow in the second half of the year. Raymond James said further shareholder upside could be unlocked if the company's balance sheet goals of lower leverage and higher free cash flow remain on track, assuming production performance continues through 2026 and 2027.

SM Energy trades at a 2027 estimated free cash flow to enterprise value ratio of approximately 14% and an enterprise value to EBITDA multiple of approximately 3x. The peer group trades at approximately 9% and 3.5x, respectively. Bond.az analysis indicates the stock remains undervalued.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...